Attenuation of Eph Receptor Kinase Activation in Cancer Cells by Coexpressed Ephrin Ligands
出版年份 2013 全文链接
标题
Attenuation of Eph Receptor Kinase Activation in Cancer Cells by Coexpressed Ephrin Ligands
作者
关键词
-
出版物
PLoS One
Volume 8, Issue 11, Pages e81445
出版商
Public Library of Science (PLoS)
发表日期
2013-11-30
DOI
10.1371/journal.pone.0081445
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme
- (2013) Bryan W. Day et al. CANCER CELL
- Cancer Somatic Mutations Disrupt Functions of the EphA3 Receptor Tyrosine Kinase through Multiple Mechanisms
- (2012) Erika M. Lisabeth et al. BIOCHEMISTRY
- Aberrant expression of EphA3 in gastric carcinoma: correlation with tumor angiogenesis and survival
- (2012) Hong-Qing Xi et al. JOURNAL OF GASTROENTEROLOGY
- Effects of Cancer-Associated EPHA3 Mutations on Lung Cancer
- (2012) Guanglei Zhuang et al. JNCI-Journal of the National Cancer Institute
- EphrinA1 Is Released in Three Forms from Cancer Cells by Matrix Metalloproteases
- (2012) A. Beauchamp et al. MOLECULAR AND CELLULAR BIOLOGY
- The cis side of juxtacrine signaling: a new role in the development of the nervous system
- (2012) Avraham Yaron et al. TRENDS IN NEUROSCIENCES
- EPHA3 as a novel therapeutic target in the hematological malignancies
- (2012) Niamh Keane et al. Expert Review of Hematology
- EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex
- (2012) Guo Li et al. Nature Communications
- Profiling Eph receptor expression in cells and tissues
- (2012) Roberta Noberini et al. Cell Adhesion & Migration
- EphB3 Is Overexpressed in Non-Small-Cell Lung Cancer and Promotes Tumor Metastasis by Enhancing Cell Survival and Migration
- (2011) X.-D. Ji et al. CANCER RESEARCH
- EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors
- (2011) RONG Biao-xue et al. CURRENT CANCER DRUG TARGETS
- TNF Superfamily Networks: bidirectional and interference pathways of the herpesvirus entry mediator (TNFSF14)
- (2011) Carl F Ware et al. CURRENT OPINION IN IMMUNOLOGY
- Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma
- (2011) H.-Q. Xi et al. JOURNAL OF CLINICAL PATHOLOGY
- Phosphoproteomic Profiling of NSCLC Cells Reveals that Ephrin B3 Regulates Pro-survival Signaling through Akt1-Mediated Phosphorylation of the EphA2 Receptor
- (2011) Sara Ståhl et al. JOURNAL OF PROTEOME RESEARCH
- Ephrin-Mediated cis-Attenuation of Eph Receptor Signaling Is Essential for Spinal Motor Axon Guidance
- (2011) Tzu-Jen Kao et al. NEURON
- Ephrin-B3 binds to a sulfated cell-surface receptor
- (2010) Halvor L. Holen et al. BIOCHEMICAL JOURNAL
- Soluble ephrin a1 is necessary for the growth of HeLa and SK-BR3 cells
- (2010) Spencer Alford et al. Cancer Cell International
- Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells
- (2010) Nai-Ying Yang et al. CELLULAR SIGNALLING
- Emerging strategies for EphA2 receptor targeting for cancer therapeutics
- (2010) Manish Tandon et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells
- (2010) Jonathan W. Astin et al. NATURE CELL BIOLOGY
- An extracellular steric seeding mechanism for Eph-ephrin signaling platform assembly
- (2010) Elena Seiradake et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures
- (2009) O. Salvucci et al. BLOOD
- CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions
- (2009) Lars Nitschke IMMUNOLOGICAL REVIEWS
- Eph Receptors and Ephrins in Cancer: Common Themes and Controversies
- (2008) J. Chen et al. CANCER RESEARCH
- Eph-Ephrin Bidirectional Signaling in Physiology and Disease
- (2008) Elena B. Pasquale CELL
- The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting
- (2008) J. Wykosky et al. MOLECULAR CANCER RESEARCH
- Somatic mutations affect key pathways in lung adenocarcinoma
- (2008) Li Ding et al. NATURE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started